Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Bonanno

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
Expert Review of Anticancer Therapy|August 7, 2018
Therapeutic approaches for T790M mutation positive non-small-cell lung cancerIlaria Attili, Niki Karachaliou, PierFranco Conte, et al.
Journal of Thoracic Disease|January 21, 2012
A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: A case reportGiulia Pasello, Giuseppe Altavilla, Laura Bonanno, et al.
AANA Journal|February 4, 2020
Development of a Common Clinical Assessment Tool for Evaluation in Nurse Anesthesia EducationSass Elisha, Laura Bonanno, Demetrius Porche, et al.
International Journal of Molecular Sciences|March 1, 2020
Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for TreatmentStefano Frega, Alessandra Ferro, Laura Bonanno, et al.
Critical Reviews in Oncology/Hematology|October 26, 2017
Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?Ilaria Attili, Antonio Passaro, Alberto Pavan, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) PatientsElisabetta Zulato, Valeria Tosello, Giorgia Nardo, et al.
Critical Reviews in Oncology/Hematology|May 17, 2019
Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?Stefano Frega, Alessandro Dal Maso, Alessandra Ferro, et al.
Oncotarget|March 3, 2016
Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterizationValentina Polo, Giulia Pasello, Stefano Frega, et al.
Critical Reviews in Oncology/Hematology|June 10, 2019
Corrigendum to "Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?" [Crit. Rev. Oncol. Hematol. 138 (June) (2019), 87-103]Stefano Frega, Alessandro Dal Maso, Alessandra Ferro, et al.
Nuclear Medicine Communications|May 3, 2019
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapyLaura Evangelista, Lea Cuppari, Jessica Menis, et al.
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
Expert Review of Anticancer Therapy|August 7, 2018
Therapeutic approaches for T790M mutation positive non-small-cell lung cancerIlaria Attili, Niki Karachaliou, PierFranco Conte, et al.
Journal of Thoracic Disease|January 21, 2012
A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: A case reportGiulia Pasello, Giuseppe Altavilla, Laura Bonanno, et al.
AANA Journal|February 4, 2020
Development of a Common Clinical Assessment Tool for Evaluation in Nurse Anesthesia EducationSass Elisha, Laura Bonanno, Demetrius Porche, et al.
International Journal of Molecular Sciences|March 1, 2020
Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for TreatmentStefano Frega, Alessandra Ferro, Laura Bonanno, et al.
Critical Reviews in Oncology/Hematology|October 26, 2017
Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?Ilaria Attili, Antonio Passaro, Alberto Pavan, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) PatientsElisabetta Zulato, Valeria Tosello, Giorgia Nardo, et al.
Critical Reviews in Oncology/Hematology|May 17, 2019
Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?Stefano Frega, Alessandro Dal Maso, Alessandra Ferro, et al.
Oncotarget|March 3, 2016
Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterizationValentina Polo, Giulia Pasello, Stefano Frega, et al.
Critical Reviews in Oncology/Hematology|June 10, 2019
Corrigendum to "Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?" [Crit. Rev. Oncol. Hematol. 138 (June) (2019), 87-103]Stefano Frega, Alessandro Dal Maso, Alessandra Ferro, et al.
Nuclear Medicine Communications|May 3, 2019
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapyLaura Evangelista, Lea Cuppari, Jessica Menis, et al.
Pageof 13